A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia

PHASE1RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 22, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Chronic Myeloid LeukemiaChronic Phase Chronic Myeloid Leukemia, BCR-ABL1 PositiveCml
Interventions
DRUG

ELVN-001

orally once or twice daily

Trial Locations (46)

1083

RECRUITING

Semmelweis Egyetem, Belgyogyaszati es Onkologiai Klinika, Budapest

3000

RECRUITING

UZ Leuven, Leuven

4000

RECRUITING

CHU Liege, Liège

6525

RECRUITING

Radboud University Medical Center, Nijmegen

7624

RECRUITING

Pecsi Tudomanyegyetem Klinikai Kozpont (University of Pecs, Clinical Centre), Pécs

9000

RECRUITING

UZ Gent, Ghent

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

10461

RECRUITING

Montefiore Medical Center, The Bronx

11749

RECRUITING

Uijeongbu Eulji Medical Center, Gyeonggi-do

13353

RECRUITING

Charite Campus Virchow, Berlin

18057

RECRUITING

Universitaetsmedizin Rostock, Rostock

28046

RECRUITING

Hospital Universitario La Paz, Madrid

33076

RECRUITING

Institut Bergonie - Centre Regional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest, Bordeaux

35010

WITHDRAWN

Hospital Universitario de Gran Canaria Dr. Negrin, Servicio Canario e Salud (SCS), Las Palmas de Gran Canaria

42601

WITHDRAWN

Keimyung University Dongsan Hospital, Daegu

45007

TERMINATED

Complejo Hospitalario de Toledo - Hospital Virgen de la Salud, Toledo

46026

RECRUITING

Universitat de Valencia - Hospital Universitari i Politecnic La Fe de Valencia (Hospital La Fe Bulevar Sur), Valencia

52074

RECRUITING

Uniklinik RWTH Aachen Medizinische, Aachen

54907

WITHDRAWN

Chonbuk National University Hospital, Jeonju

58128

WITHDRAWN

Chonnam National University Hwasun Hospital, Hwasun

59000

RECRUITING

CHRU de Lille - Hopital Calmette-Boulevard du Pr Leclercq CHRU Lille, Lille

60126

RECRUITING

Azienda Ospedaliero Universitaria Delle Marche, Ancona

60596

RECRUITING

Klinikum der Goethe Universitat, Frankfurt

66421

RECRUITING

Universitaetsklinikum Des Saarlandes Und Medizinische Fakultaet Der Universitaet Des Saarlandes, Homburg

68167

RECRUITING

Medizinische Universitatsklinik Mannheim der Universitat Heidelberg, Mannheim

69008

RECRUITING

Centre Leon Berard, Lyon

69495

RECRUITING

Centre Hospitalier Lyon Sud, Pierre-Bénite

77030

RECRUITING

The University of Texas MD Anderson Cancer Center, Houston

78157

WITHDRAWN

Centre Hospitalier de Versailles (CHV), Le Chesnay

80054

RECRUITING

CHU Amiens Picardie Site Sud, Amiens

87000

RECRUITING

Centre Hospitalier Universitaire (CHU) De Limoges Hopital Dupuytren, Limoges

97239

RECRUITING

Oregon Health & Science University-Knight Cardiovascular Institute, Portland

2210001

RECRUITING

The Galilee Medical Center, Nahariya

4941492

RECRUITING

Rabin Medical Center, Petah Tikva

9112001

RECRUITING

Hadassah Medical Center, Jerusalem

SA 5000

RECRUITING

Royal Adelaide Hospital, Adelaide

M5G 2M9

RECRUITING

University Health Network (UHN) - Princess Margaret Cancer Centre, Toronto

07747

RECRUITING

Universitaetsklinikum Jena, Jena

33-300

RECRUITING

Szpital Specjalistycnzy im. Jedrzeja Sniadeckiego w Nowym Saczu, Nowy Sącz

87-100

RECRUITING

MICS Centrum Medyczne Torun, Torun

02-776

RECRUITING

Instytut Hematologii I Transfuzjologii, Warsaw

06351

WITHDRAWN

Samsung Medical Center, Seoul

08003

RECRUITING

Hospital Del Mar, Barcelona

G12 0YN

RECRUITING

Beatson West of Scotland Cancer Centre, Gartnavel General Hospital, Glasgow

W12 0HS

RECRUITING

Hammersmith Hospital Imperial College Healthcare NHS Trust, London

M20 4BX

RECRUITING

The Christie NHS Foundation Trust, Manchester

Sponsors
All Listed Sponsors
lead

Enliven Therapeutics

INDUSTRY

NCT05304377 - A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia | Biotech Hunter | Biotech Hunter